Athira Pharma Stock Market Value
| ATHA Stock | USD 0.62 0.01 1.59% |
| Symbol | Athira |
Athira Pharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Athira Pharma. If investors know Athira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Athira Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.78) | Return On Assets (0.48) | Return On Equity (0.85) |
The market value of Athira Pharma is measured differently than its book value, which is the value of Athira that is recorded on the company's balance sheet. Investors also form their own opinion of Athira Pharma's value that differs from its market value or its book value, called intrinsic value, which is Athira Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Athira Pharma's market value can be influenced by many factors that don't directly affect Athira Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Athira Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Athira Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Athira Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Athira Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Athira Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Athira Pharma.
| 05/30/2024 |
| 11/26/2024 |
If you would invest 0.00 in Athira Pharma on May 30, 2024 and sell it all today you would earn a total of 0.00 from holding Athira Pharma or generate 0.0% return on investment in Athira Pharma over 180 days. Athira Pharma is related to or competes with CytomX Therapeutics, Spero Therapeutics, Instil Bio, NextCure, Assembly Biosciences, Achilles Therapeutics, and Nuvation Bio. Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore n... More
Athira Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Athira Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Athira Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 79.98 | |||
| Value At Risk | (9.26) | |||
| Potential Upside | 15.22 |
Athira Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Athira Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Athira Pharma's standard deviation. In reality, there are many statistical measures that can use Athira Pharma historical prices to predict the future Athira Pharma's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (1.23) | |||
| Total Risk Alpha | (3.06) | |||
| Treynor Ratio | (1.21) |
Athira Pharma Backtested Returns
Athira Pharma secures Sharpe Ratio (or Efficiency) of -0.0894, which signifies that the company had a -0.0894% return per unit of standard deviation over the last 3 months. Athira Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Athira Pharma's risk adjusted performance of (0.06), and Mean Deviation of 5.81 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.93, which signifies possible diversification benefits within a given portfolio. Athira Pharma returns are very sensitive to returns on the market. As the market goes up or down, Athira Pharma is expected to follow. At this point, Athira Pharma has a negative expected return of -1.13%. Please make sure to confirm Athira Pharma's information ratio, skewness, day typical price, as well as the relationship between the treynor ratio and daily balance of power , to decide if Athira Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.24 |
Weak reverse predictability
Athira Pharma has weak reverse predictability. Overlapping area represents the amount of predictability between Athira Pharma time series from 30th of May 2024 to 28th of August 2024 and 28th of August 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Athira Pharma price movement. The serial correlation of -0.24 indicates that over 24.0% of current Athira Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.4 |
Athira Pharma lagged returns against current returns
Autocorrelation, which is Athira Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Athira Pharma's stock expected returns. We can calculate the autocorrelation of Athira Pharma returns to help us make a trade decision. For example, suppose you find that Athira Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Athira Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Athira Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Athira Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Athira Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Athira Pharma Lagged Returns
When evaluating Athira Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Athira Pharma stock have on its future price. Athira Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Athira Pharma autocorrelation shows the relationship between Athira Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Athira Pharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Athira Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Athira Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Athira Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Athira Pharma Stock:Check out Athira Pharma Correlation, Athira Pharma Volatility and Athira Pharma Alpha and Beta module to complement your research on Athira Pharma. For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Athira Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.